公开(公告)号：US20230346762A1

公开(公告)日：2023-11-02

申请号：US17800627

申请日：2021-02-19

Applicant: KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY

Inventor： Seyun KIM ,  Boah LEE ,  Seung Ju PARK

IPC: A61K31/4468 ,  A61K31/4745 ,  A61K31/513 ,  C07K16/28 ,  A61P35/00

CPC classification number: A61K31/4468 ,  A61K31/4745 ,  A61K31/513 ,  C07K16/2818 ,  A61P35/00 ,  A61K2039/505

Abstract: The present invention relates to a pharmaceutical composition for preventing or treating cancer, containing a mTOR-signaling inhibitor as an active ingredient. The composition of the present invention exhibits the efficacy of inhibiting the growth of cancer cells and killing cancer cells, and thus can be used as an anticancer agent.